Literature DB >> 2365009

Serotonin autoreceptor subsensitivity and antidepressant activity.

C Moret1, M Briley.   

Abstract

Release of [3H]serotonin elicited by electrical stimulation from rat hypothalamus and its modulation through autoreceptors has been studied after chronic administration of two antidepressants, citalopram, specific inhibitor of serotonin uptake, and milnacipran (previously called midalcipran, F 2207) which blocks the uptake of serotonin and noradrenaline to the same extent. The amount of [3H]serotonin released by electrical stimulation was enhanced and the inhibitory effect of the agonist, LSD (lysergic acid diethylamide), reduced in rats treated with citalopram at 10 and 50 mg/kg per day for 21 days. These effects existed at both doses but were accentuated at the higher dose. Thus a chronic treatment with citalopram provokes a down-regulation of the serotonergic autoreceptor, allowing an increase of serotonin neurotransmission. After 21 days treatment with milnacipran, at 50 mg/kg per day, none of the parameters studied were modified. These data suggest that down-regulation of the serotonin autoreceptor is not a universally applicable hypothesis to explain the action of all antidepressants acting on the uptake of serotonin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2365009     DOI: 10.1016/0014-2999(90)90320-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

1.  Role of extracellular serotonin levels in the effect of 5-HT1B receptor blockade.

Authors:  Lotte de Groote; André A Klompmakers; Berend Olivier; Herman G M Westenberg
Journal:  Psychopharmacology (Berl)       Date:  2003-03-18       Impact factor: 4.530

2.  Is there action beyond receptors?

Authors:  P D Hrdina
Journal:  J Psychiatry Neurosci       Date:  1993-03       Impact factor: 6.186

3.  Effect of chronic administration of the selective serotonin (5-HT) uptake inhibitor citalopram on extracellular 5-HT and apparent autoreceptor sensitivity in rat forebrain in vivo.

Authors:  S B Auerbach; S Hjorth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-12       Impact factor: 3.000

Review 4.  Regulation of dorsal raphe nucleus function by serotonin autoreceptors: a behavioral perspective.

Authors:  Ross A McDevitt; John F Neumaier
Journal:  J Chem Neuroanat       Date:  2011-05-08       Impact factor: 3.052

5.  Diurnal variation in 5-HT1B autoreceptor function in the anterior hypothalamus in vivo: effect of chronic antidepressant drug treatment.

Authors:  T J Sayer; S D Hannon; P H Redfern; K F Martin
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

6.  Modulation of 5-HT release in the guinea-pig brain following long-term administration of antidepressant drugs.

Authors:  P Blier; C Bouchard
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

7.  Paroxetine treatment and the prolactin response to sumatriptan.

Authors:  Y K Wing; E M Clifford; B D Sheehan; G M Campling; R A Hockney; P J Cowen
Journal:  Psychopharmacology (Berl)       Date:  1996-04       Impact factor: 4.530

8.  Chronic treatment with fluvoxamine by osmotic minipumps fails to induce persistent functional changes in central 5-HT1A and 5-HT1B receptors, as measured by in vivo microdialysis in dorsal hippocampus of conscious rats.

Authors:  F J Bosker; K E van Esseveldt; A A Klompmakers; H G Westenberg
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530

Review 9.  Pharmacogenetics of antidepressant response: an update.

Authors:  Antonio Drago; Diana De Ronchi; Alessandro Serretti
Journal:  Hum Genomics       Date:  2009-04       Impact factor: 4.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.